Targeting residual inflammatory risk: The next frontier for atherosclerosis treatment and prevention
Paul M. Ridker
Topics & Concepts
Residual riskMedicineHyperlipidemiaStatinMyocardial infarctionInflammationInternal medicineDrugFood and drug administrationSimvastatinColchicineStroke (engine)CardiologyDiabetes mellitusPharmacologyEndocrinologyEngineeringMechanical engineeringLipoproteins and Cardiovascular HealthInflammasome and immune disordersAtherosclerosis and Cardiovascular Diseases